Abbott ABT Nutritional Products — Operating Earnings
Other segment segments
Other financials
Where this comes from
Reported directly by Abbott in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Abbott’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Abbott's nutritional products — operating earnings.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Abbott's nutritional products — operating earnings?
- Abbott (ABT) reported nutritional products — operating earnings of $311M in Q1 2026.
- How has Abbott's nutritional products — operating earnings changed year-over-year?
- Abbott's nutritional products — operating earnings decreased by 21.1% year-over-year, from $394M to $311M.
- What is the long-term trend for Abbott's nutritional products — operating earnings?
- Over 4 years (2021 to 2025), Abbott's nutritional products — operating earnings has grown at a -3.0% compound annual growth rate (CAGR), from $1.76B to $1.56B.
- What does nutritional products — operating earnings mean?
- The operating profit generated specifically by the nutritional products business.
- How do you interpret nutritional products — operating earnings?
- An increase signals improved profitability and operational performance, while a decrease indicates margin pressure or rising costs.
- How does nutritional products — operating earnings compare across companies?
- Standard segment operating income metric used by diversified healthcare and consumer goods conglomerates.